China Medical Device PMS Services

Effective post-market surveillance (PMS) is essential for maintaining the safety and performance of medical devices after they have been introduced to the Chinese market. Under China's evolving medical device regulation, the National Medical Products Administration (NMPA) mandates that In-Vitro Diagnostic (IVD) and medical device manufacturers establish and maintain a compliant PMS system to ensure long-term safety, effectiveness, and market access.

Medical Device Regulations
Quality Management Requirements

What is Post-Market Surveillance (PMS)?

Post-market surveillance (PMS) refers to the ongoing process of monitoring the clinical performance and device performance of medical devices and IVDs once they are commercially available. In contrast to pre-market clinical trials, PMS collects real-world clinical data through user feedback, adverse events, and market observations to ensure ongoing medical device safety.

In China, a robust post-market surveillance framework is legally required and forms an essential part of the broader quality management system. It plays a critical role in identifying risks that could lead to serious adverse health consequences or serious incidents, particularly for high-risk Class III devices.

Regulatory Overview of PMS in China

The NMPA has significantly expanded its focus on post-market surveillance, introducing regulations that emphasize real-world data, proactive risk control, and continuous compliance. Under these regulations, manufacturers must:

Ensure timely adverse event reporting (AE) through China’s National Medical Device Adverse Event Monitoring System (NMDAEM System).
Submit periodic safety update reports known in China as Periodic Risk Evaluation Reports (PRER) based on cumulative market data.
Conduct annual QMS self-assessments, including detailed reports submitted to NMPA.
Maintain a Good Manufacturing Practice (GMP) system and prepare for potential inspections.
Track local standard updates promptly and execute necessary standard upgrades before regulatory deadlines.
Submit change notifications to the NMPA promptly and apply for certificate renewal at least six months prior to expiration.

Manufacturers have specific responsibilities under NMPA regulations to ensure compliance with these requirements, including the implementation of post-market surveillance plans and maintaining the safety and performance of medical devices.

Noncompliance with these regulatory requirements may lead to enforcement actions, including certificate suspension or market withdrawal.

Core Components of a PMS System under the NMPA

To effectively meet China’s PMS requirements, IVD and medical device manufacturers must implement a structured system encompassing the following components:

1. Adverse Event Monitoring

The NMDAEM System is monitored to identify potential health risks early, especially for events that could result in adverse health consequences. AE reports must be reviewed, translated if necessary, and submitted to NMPA within prescribed timelines.

2. PRER Reports

Manufacturers of Class II and III devices must submit Periodic Risk Evaluation Reports (PRERs) summarizing cumulative risk data, trend analyses, and resulting risk mitigations. Class I manufacturers must compile PRERs and ensure the Legal Agent files them in preparation for local inspections.‍

3. Corrective & Preventive Actions (CAPA)

CAPAs are initiated in response to identified issues. These actions must address root causes, be well-documented, and include follow-up monitoring to verify effectiveness.

4. Label & IFU Compliance

Chinese-language labels and Instructions for Use (IFUs) must be reviewed to confirm they meet the NMPA’s content and formatting standards, including accurate legal agent and manufacturer details.

5. UDI & Traceability

For devices subject to China’s UDI regulation, manufacturers must maintain updated UDI-DI codes in the NMPA database and ensure traceability throughout the supply chain.

6. Annual Reports

Annual reports summarize yearly Quality Management System (QMS) self-inspections and Periodic Risk Evaluation Reports (PRER) for medical devices, with requirement cycles varying by product class.

7. Integration with QMS

PMS processes should be embedded within the organization’s certified QMS to ensure a seamless approach to compliance and continuous improvement.

Common Challenges in China PMS Compliance

PMS implementation in China is not without obstacles. IVD and medical device companies often encounter:

Fragmented or manual PMS data systems
Difficulty accessing AE data in Chinese
Complex digital platforms (e.g., E-RPS, NMDAEM, UDI systems)
Tight timelines for PRER submission and renewals

Solutions include:

Designating a reliable NMPA Legal Agent with system access
Standardizing AE handling workflows and translation procedures
Automating internal reminders for regulatory deadlines
Regularly training staff on evolving regulatory expectations.
China Post Market Surveillance Requirements

Post-Market Surveillance as Part of a QMS

Embedding PMS into the QMS framework ensures consistent, organization-wide awareness of safety obligations. A QMS is essential for meeting international standards like ISO 13485:2016, ensuring compliance with regulatory obligations. This alignment supports:

Faster response to safety issues
More accurate documentation for inspections or renewals
Improved product lifecycle planning
Stronger alignment with both ISO and NMPA requirements

Many manufacturers report better regulatory performance and reduced product release delays after integrating PMS activities into their core QMS.

For medical device companies in China, post-market surveillance is more than a compliance requirement, it is a strategic pillar of safe, effective, and sustainable operations. By aligning with NMPA’s PMS framework and integrating surveillance activities into your QMS, you enhance regulatory readiness, improve product safety, and strengthen patient trust. Active monitoring and a proactive, well-documented PMS system are the foundation for long-term success in the Chinese medical device market.

Our Post-Market Surveillance Services for NMPA Compliance

To help you perform post market surveillance activities for China, below is a non-exhaustive list 
of services we offer. We also help you build a proactive PMS strategy:

QMS Self-Assessment Support

Annual report reminders, bilingual templates, review, and submission to NMPA.

Periodic Risk Evaluation (PRER)

Guidance, review, and timely submission of PRERs in line with NMPA requirements.

Adverse Event Monitoring & Response

NMDAEM system monitoring on each working day, with full AE handling, submission, and tracking.

Annual AE Summary & Analysis

Yearly review and reporting of all adverse events to support risk management.

Regulatory News & Updates

Regular alerts on new NMPA regulations and standards affecting your product certificates.

Recall & UDI Support

Representation during recalls and assistance with UDI-DI transfers in the NMPA database.

Label & IFU Compliance 
Checks

Review of Chinese labeling and IFU content to meet NMPA standards.

Insurance & Procurement Reporting

Submission of AE and risk reports for medical insurance and centralized bidding.

It is crucial for any company to manage and improve their PMS processes efficiently, as this impacts the overall safety and effectiveness of the devices they produce.

Useful Articles

View More

China NMPA Medical Device Registration Timeline Calculator

Use our interactive calculator to estimate your China NMPA medical device registration timeline, key milestones, and approval window.

November 17, 2026
China NMPA Medical Device Registration Timeline Calculator

Do You Need a China Medical Device Clinical Trial? [Quick Check]

Answer a few quick questions and get a preliminary assessment of whether your medical device requires a China clinical trial for NMPA registration.

November 17, 2026
Do You Need a China Medical Device Clinical Trial? [Quick Check]

How the Indonesia Halal Certification Process Works (SIHALAL): A Guide to the SHLN & Regular Certification Pathways

Learn how the BPJPH process works for foreign certificates (SHLN) and regular SIHALAL applications.

November 3, 2026
How the Indonesia Halal Certification Process Works (SIHALAL): A Guide to the SHLN & Regular Certification Pathways

5-Step Guide to the GBA Connect Scheme for Medical Manufacturers

Discover how overseas medical companies can access China early via the GBA Connect Pathway, with a 5-step process and hospital coordination tips.

November 2, 2026
5-Step Guide to the GBA Connect Scheme for Medical Manufacturers

Key Requirements for Indonesia Halal Medical Devices: What Manufacturers & Importers Need to Know

Learn which products are covered by Indonesia's halal framework, the labeling and manufacturing obligations, and phased compliance timelines.

November 2, 2026
Key Requirements for Indonesia Halal Medical Devices: What Manufacturers & Importers Need to Know
A healthcare worker in a white coat checks a seated patient’s blood pressure while another medical staff member in green scrubs stands nearby holding a clipboard in a bright clinic setting.

Is a Foreign Halal Certificate Valid in Indonesia? Requirements Explained

Understand Indonesia’s foreign halal certificate requirements, including covered categories and BPJPH registration routes.

November 2, 2026
Is a Foreign Halal Certificate Valid in Indonesia? Requirements Explained
Previous
Previous

Explore Related Services

Whether you’re just starting out or are a blue-chip, access our wide range of services and solutions to help your business thrive. We also help your company conduct postmarket surveillance to ensure regulatory compliance and device safety.

China Medical Device Registration

We guide you through every step of the China medical device registration and filing process. We take care of compliance with NMPA requirements, advising you on the optimal market entry pathway, and helping you through the whole process.

Learn more

NMPA Legal Agent

We are your authorized representative in China, and fulfill your registrations and filings as well as ensuring compliance with quality and PMS requirements. 

Learn more

China Clinical Trials

You may be required to provide supplementary clinical data on Chinese patients or conduct a full clinical trial in China. Our clinical research team will advise you, prepare the study protocol and assist setting up the clinical trial in China.

Learn more

NMPA Clinical Evaluation Report

Clinical Evaluation Reports can avoid the need for a China clinical trial in some instances. Our experts can advise and prepare NMPA compliant CERs. 

Learn more

Drug Device Combination Products

We assist with the classification, registration, and compliance of combination products in China, whether drug or device led.  

Learn more

NMPA Type Testing

Our on-site test engineers coordinate and supervise type tests of your medical devices in NMPA-accredited laboratories.

Learn more

China Medical Device Quality Compliance

We help you achieve and ensure ongoing compliance with Chinese requirements.

Our experts prepare and assist you for official NMPA inspections.

Learn more

Regulatory Outsourcing

If you are seeking specific specialist expertise or have ongoing resource-intensive needs, we have a variety of solutions to meet your needs.

Learn more

Explore Our Medical Device Consulting Services Across Asia

Malaysia

Singapore

Vietnam

Taiwan

Indonesia

The Philippines

Thailand

South Korea

Hong Kong

India

Macao

Read the Latest Regulatory News

View More

China Issues GMP Inspection Guidelines for Sterile, Implant, IVD, Denture and Standalone Software Devices

China has introduced GMP inspection guidelines for sterile, implantable, IVD, custom-made denture and standalone software medical devices.

November 16, 2026
China Issues GMP Inspection Guidelines for Sterile, Implant, IVD, Denture and Standalone Software Devices
Two Chinese laboratory professionals check a benchtop blood analyzer as one loads a rack of capped sample tubes.

India Clarifies How Medical Device Software, and AI-Enabled Tools Are Regulated

India’s CDSCO releases final medical device software guidance under MDR 2017, outlining licensing routes, software risk classes, and cybersecurity standards.

November 16, 2026
India Clarifies How Medical Device Software, and AI-Enabled Tools Are Regulated
Two Indian clinicians review a chest X-ray on a tablet, where diagnostic software has flagged an area in one lung.

Singapore Updates GN-15 Medical Device Registration Guidance

Singapore’s HSA has revised GN-15 medical device registration guidance, updating submission templates, SaMD requirements and post-market expectations.

November 12, 2026
Singapore Updates GN-15 Medical Device Registration Guidance

Indonesia Extends Mandatory Halal Certification Deadlines

Indonesia extends halal certification deadlines for medicines, medical devices, cosmetics, and other regulated products, giving additional time to meet compliance requirements.

November 3, 2026
Indonesia Extends Mandatory Halal Certification Deadlines

China Issues Battery Registration Guidance for Active Implantable Medical Devices

See how China’s new battery registration guidance affects technical documentation, supplier coordination, and NMPA review of active implantable medical devices.

November 2, 2026
China Issues Battery Registration Guidance for Active Implantable Medical Devices

China Issues Clinical Trial Guidance for Implantable Brain-Computer Interface Systems

China's CMDE guidance defines clinical trial and registration considerations for implantable BCI devices, including patient selection, endpoints, and post-market follow-up.

November 2, 2026
China Issues Clinical Trial Guidance for Implantable Brain-Computer Interface Systems
Previous
Previous

Get in Touch with Our Life Sciences Team

And discover how we can assist your PMS activities for your medical device or IVD in China. Our efforts are focused on continuously monitoring and collecting data for China compliance. Request a free consultation for efficient PMS and risk management to enhance the overall safety and effectiveness of your devices.

Talk to an Expert